Trial Profile
Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 15 Jun 2021
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary) ; Varenicline (Primary)
- Indications Obesity; Smoking withdrawal
- Focus Therapeutic Use
- 29 May 2020 Status changed from suspended to discontinued.
- 17 Feb 2020 Planned End Date changed from 1 Dec 2020 to 17 Feb 2020.
- 17 Feb 2020 Planned primary completion date changed from 1 Aug 2020 to 17 Feb 2020.